AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2023
Sep 15, 2023
34301_dirs_2023-09-15_9283b07d-b3aa-4dc7-aaba-3ad1685391da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2023-09-13
Reporting Person: Clowes Howard (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | Common Stock | P | 6993 | $1.4331 | Acquired | 11693 | Direct |
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 13